Advertisement
Advertisement
LGND
Ligand Pharmaceuticals Inc.
307.85
USDSponsored
+8.85
+2.96%
Nov 06, 13:49 UTC -5
Open
Ligand Pharmaceuticals Inc. (LGND)
Ligand Pharmaceuticals Inc. Financial Snapshot
| Market Cap | 6.16B |
| Beta | 1.16 |
| Earnings Per Share (EPS) | 2.24 |
| Price-to-Book (P/B) Ratio | 6.57 |
| Operating Margin | 20.27% |
| Total Debt/Equity (D/E) | 117.31% |
| P/E Ratio | 141.13 |
| Return on Equity (ROE) | 5.22% |
| Current Ratio | 1.22% |
| Free Cash Flow | 44.72M |
